Indian high court makes landmark verdict on drug patents

In a setback for the makers of branded drugs, the Indian Supreme Court dismissed Novartis' petition for patent protection for its cancer treatment Glivec. The landmark ruling reshapes the landscape for intellectual property disputes in the country and is likely to affect many other drugmakers. The decision will be an obstacle to bringing new treatments to patients, an executive with Novartis India said.

View Full Article in:

Bloomberg · LiveMint.com/The Wall Street Journal (India) · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health